Current reports
6-K
CENTOGENE Receives Nasdaq Non-Compliance Notice
2 Apr 24
6-K
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
19 Mar 24
6-K
Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected
29 Feb 24
6-K
CENTOGENE Explores Strategic Alternatives
28 Feb 24
6-K
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
28 Feb 24
6-K
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
25 Jan 24
6-K
CENTOGENE Receives French Research Tax Credit Accreditation
24 Jan 24
6-K
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
23 Jan 24
6-K
CENTOGENE Announces Preliminary Full Year 2023 Revenue
18 Jan 24
6-K
CENTOGENE Announces Voting Results of Extraordinary General Meeting
19 Dec 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
10 Jul 20
F-1
Registration statement (foreign)
7 Jul 20
DRS
Draft registration statement
26 Jun 20
DRSLTR
Correspondence regarding draft registration statement
26 Jun 20
424B4
Prospectus supplement with pricing info
8 Nov 19
S-8
Registration of securities for employees
7 Nov 19
8-A12B
Registration of securities on exchange
4 Nov 19
F-1/A
Registration statement (foreign) (amended)
28 Oct 19
F-1
Registration statement (foreign)
11 Oct 19
DRSLTR
Correspondence regarding draft registration statement
28 Mar 19
Proxies
No filings
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
17 May 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
31 Mar 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
15 Apr 21
EFFECT
Notice of effectiveness
10 Jul 20
CORRESP
Correspondence with SEC
7 Jul 20
CORRESP
Correspondence with SEC
7 Jul 20
UPLOAD
Letter from SEC
30 Jun 20
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
23 Apr 20
EFFECT
Notice of effectiveness
7 Nov 19
CERT
Certification of approval for exchange listing
6 Nov 19
Ownership
SC 13D/A
TVM Life Science Innovation I L.P.
11 Mar 22
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
22 Feb 22
SC 13G
PLATINUM INVESTMENT MANAGEMENT LTD
9 Dec 21
144
Notice of proposed sale of securities
12 Jul 21
144
Notice of proposed sale of securities
7 Jul 21
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
12 May 21
SC 13G/A
Rolfs Arndt
16 Feb 21
144
Notice of proposed sale of securities
27 Jan 21
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
5 Nov 20
SC 13D/A
TVM Life Science Innovation I L.P.
3 Nov 20